The current screen for infertility is quite simply to try to conceive over a period of 12 months. Only then, if there is still no pregnancy, are couples eligible for further diagnosis and treatment. For the estimated one in six of the 512 million couples in reproductive age worldwide thought to be infertile, this period not only prolongs anxiety unnecessarily but also reduces the probability of success once treatment does begin. The success of treatments such as in vitrofertilization (IVF) drops off sharply as the woman—and hence the ovary—gets older. A 40-year-old is less than half as likely to achieve a pregnancy as a 30-year-old. Couple this with the social trend towards delaying childbirth (the number of US women who have their first child over the age of 30 has doubled in the last 25 years) and there is a strong case for earlier diagnosis of infertility.
This is what Genosis Ltd. hopes to provide with its Fertell OTC screening kit. The company is developing both male and female fertility tests, which couples can use at...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?